Article Details
Retrieved on: 2021-07-28 14:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In June, GSK and Alector forged a deal to develop monoclonal antibody candidates aimed at a range of neurodegenerative diseases. Two of Alector's ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here